Stay updated on Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision/version string was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the clinical study record details.
    Difference
    0.0%
    Check dated 2026-04-24T06:29:11.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the revision history.
    Difference
    0.0%
    Check dated 2026-04-17T02:47:37.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Location name updated from Padua to Padova for the Veneto, Italy site (35128).
    Difference
    0.0%
    Check dated 2026-04-09T21:43:51.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0 with the v3.4.3 label removed.
    Difference
    0.0%
    Check dated 2026-03-19T06:26:01.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision labels updated: v3.4.3 added and v3.4.2 removed.
    Difference
    0.0%
    Check dated 2026-03-12T02:32:37.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the site, and the previous funding-status notice (v3.4.1) was removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:25:01.000Z thumbnail image

Stay in the know with updates to Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.